Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1604 participants
OBSERVATIONAL
2014-04-30
2021-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reveal LINQ™ Heart Failure
NCT02758301
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System
NCT01965899
Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States
NCT02395536
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements
NCT03608826
Implantable Cardiac Monitors in High-Risk Post-Infarction Patients With Cardiac Autonomic Dysfunction
NCT02594488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reveal LINQ
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is intended to receive or be treated with the have a Reveal LINQ ICM inserted in the next 30 days.
* Patient enrolled before or on the same date of insertion of the Reveal LINQ ICM
* Subject consent prior to ICM insertion
Exclusion Criteria
* Subject is currently enrolled in or plans to enroll a concurrent study that may confound the results of this study. Co-enrollment in any concurrent drug and/or device clinical study (including registries) requires approval of the study manager or designee.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suneet Mittal, M.D.
Role: PRINCIPAL_INVESTIGATOR
The Valley Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of California San Francisco UCSF Medical Center
San Francisco, California, United States
Jacksonville Heart (Baptist Medical)
Jacksonville, Florida, United States
Bay Heart Group
Tampa, Florida, United States
Iowa Heart Center
Des Moines, Iowa, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Washington Adventist Hospital
Takoma Park, Maryland, United States
Saint Lukes Health System
Kansas City, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
The Valley Hospital
Ridgewood, New Jersey, United States
NYU Langone Medical Center
New York, New York, United States
The Christ Hospital
Cincinnati, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Lehigh Valley Health Network
Allentown, Pennsylvania, United States
Geisinger Medical Center
Danville, Pennsylvania, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
Baylor Research Institute (Dallas-TX)
Dallas, Texas, United States
Baylor Research Institute (Fort Worth TX)
Fort Worth, Texas, United States
Baylor Research Institute (Plano TX)
Plano, Texas, United States
Aurora Cardiovascular Services
Milwaukee, Wisconsin, United States
Ziekenhuis Oost Limburg - Campus St.-Jan
Leuven, , Belgium
Evaggelismos Hospital
Athens, , Greece
The Chaim Sheba Medical Center
Tel Litwinsky, , Israel
Ospedale classificato ed equiparato Sacro Cuore
Negrar, , Italy
Presidio Ospedaliero Santa Maria del Carmine
Rovereto, , Italy
National Kyushu Medical Center
Fukuoka, , Japan
Saitama Medical University International Medical Center
Hidaka, , Japan
Hirosaki University Hospital
Hirosaki, , Japan
Hospital of the University of Occupational and Environmental Health
Kitakyushu, , Japan
Saiseikai Kumamoto Hospital
Kumamoto, , Japan
Kyorin University Hospital
Mitaka, , Japan
Iwate Medical University Hospital
Morioka, , Japan
Okayama University Hospital
Okayama, , Japan
Ogaki Municipal Hospital
Ōgaki, , Japan
Showa University Hospital
Shinagawa-Ku, , Japan
National Cerebral and Cardiovascular Center
Suita, , Japan
The Jikei University School of Medicine Hospital
Tokyo, , Japan
Toho University Omori Medical Center
Tokyo, , Japan
Fujita Health University Hospital
Toyoake, , Japan
Catharina Ziekenhuis
Eindhoven, , Netherlands
Maastricht Universitair Medisch Centrum (MUMC)
Maastricht, , Netherlands
Centro Hospitalar Lisboa Ocidental - Hospital de Santa Cruz
Carnaxide, , Portugal
Hospital Senhora da Oliveira, Guimaraes
Guimarães, , Portugal
Centro Hospitarlar Lisboa Norte - Hospital de Santa Maria
Lisbon, , Portugal
Hospital do Espirito Santo
Ponta Delgada, , Portugal
Centro Hospitalar do Porto - Hospital de Santo Antonio
Porto, , Portugal
Hospital Distrital de Santarem
Santarém, , Portugal
King Fahd Armed Forces Hospital
Jeddah, , Saudi Arabia
Prince Sultan Cardiac Center
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Beinart SC, Natale A, Verma A, Amin A, Kasner S, Diener HC, Del Greco M, Wilkoff BL, Pouliot E, Franco N, Mittal S. Real-world comparison of in-hospital Reveal LINQ insertable cardiac monitor insertion inside and outside of the cardiac catheterization or electrophysiology laboratory. Am Heart J. 2019 Jan;207:76-82. doi: 10.1016/j.ahj.2018.10.002. Epub 2018 Oct 14.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Reveal LINQ Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.